Article

Formulationbio: A Leading Manufacturer of Excipients for Pharmaceutical Preparation

Topic: Business DevelopmentPublished February 19, 2021
No ratings yet337 viewsSign in to rate
Excipients are of vital importance in the process of drug development. A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for excipients, Formulationbio supplies a wide range of excipients for different research purposes, including binders, lubricants, diluents, disintegrants, emulsifiers, plasticizers, surfactants, sweeteners, fillers, stabilizers and so on.  rnAn excipient is any component, other than the active substance, present in a medicinal product or used in the manufacture of the product. They have multiple functions and often act as a carrier for the active substance.   “As a leading manufacturer of excipients, Formulationbio has served the pharmaceutical industry for years. We launch varieties of excipients to help improve the performance of our clients’ drug products. The pharmaceutical excipients we developed and produced can be used for solid, semi-solid and liquid dosage forms,” says a spokesperson from Formulationbio. “In addition, we can provide custom pharmaceutical excipients services, such as preformulation, formulation and analytical testing of excipients, to address the needs and formulation challenges of our customers.”  rnThe excipients provided at Formulationbio include, but are not limited to:   Binder Excipients Binder excipients are formulated to act as an adhesive to bind together dry ingredients such as powders and granules. They can also give volume to low active dose tablets. Some of the binder excipients provided by Formulationbio are: Cellactose 80, KG Grade Microcrystalline Cellulose, UF Grade Microcrystalline Cellulose, Formulationbio 720 for Direct Compression, etc.   Disintegrant Excipients Disintegrants are excipients used to enhance the disintegration process of tablet formulation when they make contact with GIT fluid. Some of the disintegrant excipients provided by Formulationbio are: Ludiflash, Primellose Croscarmellose sodium, Primojel Sodium starch glycolate, Solani Amylum Native potato starch, SuperStarch 200 Partly pregelatinised maize starch and more.  rnFiller ExcipientsrnFiller excipients are used to increase the volume of the material to enable easier processing of the ingredients and make it into a size suitable for consumption. Also, they can stabilize the product and help during manufacturing.  rnLubricant ExcipientsrnLubricant excipients such as RetaLac and Colloidal Silicon Dioxide can decrease friction between the pharmaceutical formulations particles and the tableting equipment contact surfaces.  rnSweetener ExcipientsrnSweetening agent excipients are substances that sweeten and mask the taste of food, beverages, and medications to make them palatable to the consumer. To name a few here: Tablettose 100, Tablettose 70, Dextrose anyhdrous C, Dextrose monohydrate GC, Glucose syrups, HI-SWEET 42 High Fructose Corn Syrup, HI-SWEET 55 High Fructose Corn Syrup, LYCASIN 75/75 HBC Maltitol Syrup.  rnCoating Systems ExcipientsrnCoatings are added to tablets to help make large, difficult to swallow pills easier to take. They also have other benefits, for example, to prevent deterioration from water and moisture and to allow for breakdown in a specific organ in the body. Some of the coating systems excipients provided by Formulationbio are: CELPHERE MCC Spherical Seed Core, SWELSTAR Pregelatinized Starch NF MX-1(Sustained release matrix agent), Anhydrous Glycerol, Dibutyl Sebacate, METHOCEL Premium CR Cellulose Ether, and VIVACOAT A - Ready-to-Use Coating System.  rnIn addition to the above-mentioned excipients, Formulationbio also offers emulsifier excipients, lipid excipients, taste masking excipients as well as other types of excipients for pharmaceutical research. For more information, please visit: https://www.formulationbio.com/products.html.

Further reading

Further Reading

4 total

Article

Artificial intelligence continues to dominate business conversations, but enthusiasm alone does not guarantee results. While many companies rush to adopt AI in hopes of gaining a competitive edge, a large number of initiatives still fall short. The problem is rarely the technology itself. More often, failure happens because organizations approach AI without the structure, readiness, and discipline required for long-term success. AI projects do not fail because the technology

March 4, 2026

Article

AI Avatar Development: Real Innovation or Just Hype? In today’s hyperconnected world, attention is currency. To stand out, brands can no longer settle for flashy features or surface-level engagement. They need to build meaningful, scalable, and personalized experiences. Enter AI avatars: digital humans that are revolutionizing communication by bringing lifelike presence to virtual interactions. Imagine a team member who never takes a coffee break, speaks ten languages fluen

February 27, 2026

Article

The Quiet Engine Behind Every Connection Most people think of telecom services as towers, signals, and mobile data moving invisibly through the air. Yet behind every call that connects and every message that reaches its destination, there is another system quietly working in the background. That system is the call center. While customers often interact with telecom companies only when something goes wrong, these centers operate constantly, guiding problems toward solutions an

February 23, 2026

Article

Introduction The solar industry once believed that collecting as many leads as possible was the fastest path to growth. Marketing teams focused on filling databases with names, phone numbers, and email addresses. At first, the numbers looked promising. Dashboards showed rising interest and more inquiries than ever before. Yet behind the scenes, many companies began to notice a quiet problem. Revenue growth did not match the flood of leads. Sales teams felt overwhelmed, conver

February 6, 2026